These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 31255507

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Use of activated charcoal in a simulated poisoning with acetaminophen: a new loading dose for N-acetylcysteine?
    Chamberlain JM, Gorman RL, Oderda GM, Klein-Schwartz W, Klein BL.
    Ann Emerg Med; 1993 Sep; 22(9):1398-402. PubMed ID: 8363113
    [Abstract] [Full Text] [Related]

  • 24. Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen.
    Galanello R, Piga A, Cappellini MD, Forni GL, Zappu A, Origa R, Dutreix C, Belleli R, Ford JM, Rivière GJ, Balez S, Alberti D, Séchaud R.
    J Clin Pharmacol; 2008 Apr; 48(4):428-35. PubMed ID: 18281442
    [Abstract] [Full Text] [Related]

  • 25. Influence of food and diabetes on pharmacokinetics of sodium tungstate in rat.
    Le Lamer-Déchamps S, Poucheret P, Cros G, Bressolle F.
    Int J Pharm; 2002 Nov 06; 248(1-2):131-9. PubMed ID: 12429467
    [Abstract] [Full Text] [Related]

  • 26. Activated charcoal interrupts enteroenteric circulation of phenobarbital.
    Wakabayashi Y, Maruyama S, Hachimura K, Ohwada T.
    J Toxicol Clin Toxicol; 1994 Nov 06; 32(4):419-24. PubMed ID: 8057401
    [Abstract] [Full Text] [Related]

  • 27. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD, Peng B, Bailey CK, Wire MB, Deng Y, Park JW, Collins DA, Kapsi SG, Jenkins JM.
    Clin Ther; 2009 Apr 06; 31(4):764-76. PubMed ID: 19446149
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal.
    Pond SM, Olson KR, Osterloh JD, Tong TG.
    JAMA; 1984 Jun 15; 251(23):3104-8. PubMed ID: 6726981
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluation of orally administered activated charcoal on intestinal dialysis of intravenously administered M79175, an aldose reductase inhibitor, in rats.
    Arimori K, Mishima M, Iwaoku R, Nakano M.
    J Pharmacobiodyn; 1987 Jun 15; 10(6):243-9. PubMed ID: 3118006
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.
    Modi NB, Veng-Pedersen P, Wurster DE, Berg MJ, Schottelius DD.
    Pharm Res; 1994 Feb 15; 11(2):318-23. PubMed ID: 8165195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.